Newmont (NEM) Q3 2026 (USD): Adj. EPS 2.20 (exp. 2.06), Revenue 6.36bln (exp. 6.30bln), Adj. EBITDA 3.95bln (exp. 3.73bln)
Newsquawk Staff ·
Newmont (NEM) Q3 2026 (USD): Adj. EPS 2.20 (exp. 2.06), Revenue 6.36bln (exp. 6.30bln), Adj. EBITDA 3.95bln (exp. 3.73bln)
What it means
Beats on all three headline lines for a senior gold producer tend to read as a margin story first: with the metal price largely marked to market by the sector, the variable that separates results is unit cost performance, so the all-in sustaining cost line and any revision to full-year cost and production guidance carry more weight than the EPS print itself. The distinction worth drawing is between beats driven by realised price and volumes, which peers in the gold space share and which the market treats as beta, and beats driven by cost control at specific operations, which is the idiosyncratic part that tends to hold in the stock. Newmont's prior form in recent reporting seasons has made guidance credibility a recurring focus, since integration and portfolio-shaping programs at the majors have historically produced quarters where operating results and outlook language diverge. The follow-ons are the conference call commentary on capital returns, debt reduction pacing, and any update on asset sales, plus the read-across to the rest of the gold peer set when it reports. With a beat across EPS, revenue and EBITDA simultaneously, the initial reaction in comparable print patterns has usually tracked the size of the cost surprise rather than the headline delta.
Sources
- Bloom Energy (BE) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.69), Revenue 1.24bln (exp. 1.06bln)
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone
- DataDog (DDOG) recently offered almost USD 4bln to acquire Upwind Security, but the Co. hasn't accepted the offer, reports The Information citing sources
- Statnews posts on X, "Rumors are swirling that the Treasury Department this week is going to propose a rule that restricts U.S. investment in the Chinese biotech sector"
Related headlines
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED3 hours ago
- State of Rhode Island sues Meta (META) over alleged tolerance for scam advertising4 hours ago
- Uber (UBER) puts all 30,000 employees on ChatGPT Work4 hours ago
- Elon Musk makes USD 1bln investment in Skydance (SKYD), Semafor reports4 hours ago
- Newsquawk Daily US Earnings Estimates - 23rd October 2026: AXP4 hours ago
- Nvidia (NVDA) launches Minerva platform for end-to-end AI factory observability5 hours ago
- SpaceX's (SPCX) SpaceXSI names Bain, Nvidia (NVDA) and Snowflake (SNOW) as launch partners5 hours ago
- Fireblocks denies talks with Visa (V), CoinDesk reports5 hours ago
- The Canadian Government is giving Cleveland-Cliffs (CLF) 15 days to restore jobs at Stelco, Globe and Mail reports6 hours ago
- Kaiser Aluminum (KALU) says demand has strengthened further since July, with aerospace, high-strength, packaging and general engineering exceeding initial FY26 expectations6 hours ago
- Norfolk Southern (NSC) says tightening truck capacity is improving rail competitiveness, supporting truck-to-rail conversions and stronger customer demand6 hours ago
- US EQUITY OPEN: Mag-7 earnings lead Tech and Indices lower as the Middle East situation remains fragile6 hours ago
- Procter & Gamble (PG) CFO says 'so far, consumer has held up, we don't know if that's going to continue'6 hours ago
- Meta's (META) 5yr CDS hits an all-time high at 114.5bps6 hours ago
- Newsquawk Daily US Equity Opening News - TSLA & META fall after earnings; TSLA & SPCX said to target H1 2027 merger7 hours ago